Sign in
4

Changes in Ownership

Aligos Therapeutics, Inc. Filed Acc 0001610717-24-000101

Options or other derivatives

  • Director acquired 8,823 shares (grant or award)
  • Director returned 30,000 shares (to the company)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Scopa James Paul Director 2024-02-27 Returned to the company · Stock Option (Right to Buy) −30,000 0 D
Scopa James Paul Director 2024-02-28 Grant or award · Stock Option (Right to Buy) +8,823 8,823 D
Loading xslF345X05/form4.xml…